Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | BMY | AMGN | MRNA | GILD |
| Company | Biomarin Pharmaceuticals | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 89.67 | 48.21 | 264.63 | 102.37 | 66.25 |
| High | 90.18 | 48.67 | 267.64 | 103.80 | 66.72 |
| Low | 88.82 | 48.12 | 260.68 | 101.29 | 66.16 |
| Last | 88.87 | 48.58 | 266.90 | 101.25 | 66.36 |
| Change | -1.20 | +0.28 | +4.15 | -0.75 | +0.20 |
| % Change | -1.33% | +0.58% | +1.58% | -0.74% | +0.30% |
| Volume | 581,062 | 3,163,985 | 983,582 | 963,833 | 2,928,304 |
| 20-Day Average Volume | 1,316,532 | 10,928,166 | 2,123,125 | 3,174,940 | 6,060,265 |
| Previous Close | 90.07 | 48.30 | 262.75 | 102.00 | 66.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 88.59 | 50.84 | 272.45 | 105.35 | 69.88 |
| 20-Day Raw Stochastic | 53.30% | 14.51% | 21.41% | 26.20% | 5.65% |
| 20-Day Relative Strength | 51.53% | 39.35% | 41.46% | 48.76% | 29.02% |
| Weighted Alpha | -6.56 | -29.54 | +6.41 | -19.83 | -24.97 |
| Today's Opinion | 16% Sell | 72% Sell | 56% Sell | 72% Buy | 100% Sell |
| Previous Opinion | 8% Buy | 72% Sell | 56% Sell | 72% Buy | 100% Sell |
| Last Month's Opinion | 88% Sell | 24% Sell | 8% Sell | 56% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.56% since 04/12/24 | +0.68% since 04/12/24 | -0.24% since 04/12/24 | -3.03% since 04/12/24 | -2.53% since 04/12/24 |
| Low | 88.89 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 99.90 on 04/18/24 | 65.90 on 04/18/24 |
| High | 93.36 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 106.42 on 04/16/24 | 68.46 on 04/15/24 |
| 1-Month | |||||
| %Chg | +4.30% since 03/19/24 | -6.16% since 03/19/24 | -1.87% since 03/19/24 | -3.01% since 03/19/24 | -9.62% since 03/19/24 |
| Low | 83.82 on 03/20/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.90 on 04/18/24 |
| High | 93.36 on 04/15/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -3.59% since 01/19/24 | -2.99% since 01/19/24 | -13.37% since 01/19/24 | +2.26% since 01/19/24 | -23.99% since 01/19/24 |
| Low | 83.44 on 03/15/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.90 on 04/18/24 |
| High | 94.51 on 01/23/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +7.69% since 10/19/23 | -13.93% since 10/19/23 | -4.97% since 10/19/23 | +23.77% since 10/19/23 | -15.41% since 10/19/23 |
| Low | 76.02 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.90 on 04/18/24 |
| High | 99.56 on 12/14/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,999,272 | 97,892,464 | 140,812,720 | 39,053,760 | 82,374,304 |
| Shares Outstanding, K | 188,734 | 2,026,759 | 535,919 | 382,880 | 1,245,077 |
| Annual Sales | 2,419,230,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | 167,650,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 646,210,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
| Last Quarter Net Income | 20,380,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.31 | 0.39 | 0.58 | 1.62 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 04/24/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 72.38 | 6.38 | 14.16 | 0.00 | 9.96 |